Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease

Area of Science:

• Neuroscience
• Neurology

Background:

• Parkinson disease (PD) is a neurodegenerative disorder affecting dopamine pathways.
• Sleep disturbances, including excessive daytime sleepiness, are common in PD patients.

Purpose of the Study:

• To examine the association between hypothalamic dopamine D3 receptor availability and sleep problem severity in Parkinson disease.
• Investigate the role of dopamine D3 receptors in PD-related sleep issues.

Main Methods:

• Positron Emission Tomography (PET) imaging was used with the dopamine D3 receptor radioligand [11C]-propyl-hexahydro-naphtho-oxazin ([11C]-PHNO).
• Twelve PD patients underwent PET scans.
• Sleep problem severity was assessed using the Unified Parkinson's Disease Rating Scale (UPDRS) and Epworth Sleepiness Scale (ESS).

Main Results:

• Lower dopamine D3 receptor availability in the hypothalamus correlated with increased severity of excessive daytime sleepiness.
• No significant association was found between dopamine D3 receptor availability and difficulty falling asleep or insomnia.

Conclusions:

• Hypothalamic dopamine D3 receptor availability reduction is associated with excessive daytime sleepiness in Parkinson disease.
• These findings suggest that targeting the dopaminergic D3 system may offer a therapeutic strategy to enhance daytime alertness in PD patients.
• Further research with larger cohorts and polysomnography is warranted to confirm these preliminary results.